Pelizaeus-Merzbacher disease in patients with molecularly confirmed diagnosis
Pelizaeus-Merzbacher disease (PMD) is X-linked hypomyelinating leukodystrophy caused by mutations of the PLP1 gene, which codes the proteolipid protein 1. The result of mutations is abnormal myelination – hypomyelination and dysmyelination of cerebral white matter, and in some form of the disease hy...
Main Authors: | Hanna Mierzewska, Ewa Jamroz, Tomasz Mazurczak, Dorota Hoffman-Zacharska, Elżbieta Szczepanik |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2016-03-01
|
Series: | Folia Neuropathologica |
Subjects: | |
Online Access: | https://www.termedia.pl/Pelizaeus-Merzbacher-disease-in-patients-with-molecularly-confirmed-diagnosis,20,27231,1,1.html |
Similar Items
-
DISEASE MODELING AND THERAPEUTIC DEVELOPMENT FOR PELIZAEUS-MERZBACHER DISEASE
by: Elitt, Matthew S.
Published: (2019) -
Subclinical hypothyroidism and Pelizaeus-Merzbacher Disease in same-sex twins: Case report
by: Andrea Marcia Pereira Vieira, et al.
Published: (2021-12-01) -
A novel non-human primate model of Pelizaeus-Merzbacher disease
by: Larry S. Sherman, et al.
Published: (2021-10-01) -
Pelizaeus-Merzbacher Disease, Easily Misdiagnosed as Cerebral Palsy: A Report of a Three-generation Family
by: Yen-Chun Chen, et al.
Published: (2014-04-01) -
Exome sequencing reveals a novel PLP1 mutation in a Moroccan family with connatal Pelizaeus-Merzbacher disease: a case report
by: Jaber Lyahyai, et al.
Published: (2018-02-01)